Want to join the conversation?
$EBS received FDA approval for its sBLA to expand label of BioThrax (Anthrax Vaccine Adsorbed) to include post-exposure prophylaxis (PEP) of disease after suspected or confirmed Bacillus anthracis exposure when administered in conjunction with recommended antibacterial drugs. BioThrax is only FDA-licensed vaccine to prevent anthrax.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?